Resultats de la cerca - Patrick Engelberts

  • Mostrar 1 - 9 resultats de 9
Refinar resultats
  1. 1
    Regulation of the Pap Epigenetic Switch by CpxAR

    Regulation of the Pap Epigenetic Switch by CpxAR per Aaron D. Hernday, Bruce A. Braaten, Gina Broitman-Maduro, Patrick Engelberts, David A. Low

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors

    Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors per Jim Middelburg, Kristel Kemper, Patrick Engelberts, Aran F. Labrijn, Janine Schuurman, Thorbald van Hall

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Exhaustion of Cytotoxic Effector Systems May Limit Monoclonal Antibody-Based Immunotherapy in Cancer Patients

    Exhaustion of Cytotoxic Effector Systems May Limit Monoclonal Antibody-Based Immunotherapy in Cancer Patients per Frank J. Beurskens, Margaret A. Lindorfer, Mohammed Farooqui, Paul V. Beum, Patrick Engelberts, Wendy J.M. Mackus, Paul W.H.I. Parren, Adrian Wiestner, Ronald P. Taylor

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells

    Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalizatio... per Paul V. Beum, Elizabeth M. Peek, Margaret A. Lindorfer, Frank J. Beurskens, Patrick Engelberts, Paul W.H.I. Parren, Jan G. J. van de Winkel, Ronald P. Taylor

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy

    Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy per Fabio Da Roit, Patrick Engelberts, Ronald P. Taylor, Esther C.W. Breij, Giuseppe Gritti, Alessandro Rambaldi, Martino Introna, Paul W.H.I. Parren, Frank J. Beurskens, Josée Golay

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface

    A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface per Rob N. de Jong, Frank J. Beurskens, Sandra Verploegen, Kristin Strumane, Muriel D. van Kampen, Marleen Voorhorst, Wendy Horstman, Patrick Engelberts, Simone C. Oostindie, Guanbo Wang, Albert J. R. Heck, Janine Schuurman, Paul W.H.I. Parren

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation

    Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation per Ewald TJ van den Bremer, Frank J. Beurskens, Marleen Voorhorst, Patrick Engelberts, Rob N. de Jong, Burt G van der Boom, Erika M. Cook, Margaret A. Lindorfer, Ronald P. Taylor, Patrick HC van Berkel, Paul W.H.I. Parren

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing

    DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing per Patrick Engelberts, Ida H. Hiemstra, Bart de Jong, Danita H. Schuurhuis, Joyce Meesters, Irati Beltrán Hernández, Simone C. Oostindie, Joost Neijssen, Edward N. van den Brink, G. Jean Horbach, Sandra Verploegen, Aran F. Labrijn, Theodora W. Salcedo, Janine Schuurman, Paul W.H.I. Parren, Esther C.W. Breij

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20

    Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20 per Magdalena Winiarska, Jacek Bil, Ewa Wilczek, Grzegorz M. Wilczyński, Małgorzata Lekka, Patrick Engelberts, Wendy J.M. Mackus, Elżbieta Górska, Łukasz Bojarski, Tomasz Stokłosa, Dominika Nowis, Zuzanna Kurzaj, Marcin Makowski, Eliza Głodkowska‐Mrówka, Tadeusz Issat, Piotr Mrówka, Witold Lasek, Anna Dąbrowska‐Iwanicka, Grzegorz Basak, M Wasik, Krzysztof Warzocha, Maciej Siński, Zbigniew Gaciong, Marek Jakóbisiak, Paul W.H.I. Parren, Jakub Gołąb

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: